Platform Technology Partners Sells 112 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Platform Technology Partners cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,975 shares of the healthcare conglomerate’s stock after selling 112 shares during the period. Platform Technology Partners’ holdings in UnitedHealth Group were worth $2,011,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Generate Investment Management Ltd raised its position in UnitedHealth Group by 54.0% during the 4th quarter. Generate Investment Management Ltd now owns 67,628 shares of the healthcare conglomerate’s stock valued at $34,210,000 after purchasing an additional 23,710 shares in the last quarter. Harvey Investment Co. LLC lifted its stake in UnitedHealth Group by 4.1% in the fourth quarter. Harvey Investment Co. LLC now owns 4,841 shares of the healthcare conglomerate’s stock worth $2,449,000 after acquiring an additional 190 shares during the period. Lecap Asset Management Ltd. lifted its position in shares of UnitedHealth Group by 457.2% in the 4th quarter. Lecap Asset Management Ltd. now owns 5,633 shares of the healthcare conglomerate’s stock worth $2,850,000 after purchasing an additional 4,622 shares during the period. Golden State Wealth Management LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $867,000. Finally, Archer Investment Corp boosted its position in UnitedHealth Group by 10.3% during the 4th quarter. Archer Investment Corp now owns 2,777 shares of the healthcare conglomerate’s stock valued at $1,405,000 after acquiring an additional 259 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $526.68 on Friday. The firm’s 50 day simple moving average is $530.85 and its 200-day simple moving average is $564.52. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $484.69 billion, a price-to-earnings ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm earned $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.